Invitae News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.02.24	Invitae Files For Chapter 11 Bankruptcy Protection (RTTNews)
22.01.24	Natera Acquires Assets From Invitae (RTTNews)
02.10.23	FDA Approves Invitae's DNA Test To Assess Predisposition For Certain Cancers (RTTNews)
15.08.23	Invitae Says Clinical Trial Results Support Genetic Testing Of Patients With Prostate Cancer (RTTNews)
11.11.22	Pre-market Movers: SNAL, VS, OLMA, MTTR, HLTH… (RTTNews)
09.11.22	Pre-market Movers: MACK, IXHL, UPST, CARG, ELBM… (RTTNews)
11.08.22	Pre-market Movers: SWX, GWAV, CSSE, NVTA, SONO… (RTTNews)
19.07.22	Pre-market Movers: CVM, SRGA, USEA, WETG, NRGV… (RTTNews)
15.06.22	Pre-market Movers: REV, ASTL, VNRX, VORB, GGR… (RTTNews)
10.01.22	Invitae 2021 Revenue Up Approx. 64%; Billable Volumes Up 76% - Quick Facts (RTTNews)
07.09.21	Invitae To Acquire Ciitizen - Quick Facts (RTTNews)
09.08.21	Invitae to Present at the UBS Genomics 2.0 and MedTech Innovations Summit (PR Newswire)
03.08.21	Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021 (PR Newswire)
22.07.21	Volpara Collaborates With Invitae Corporation, Leading Genetics Company (PR Newswire)
20.07.21	Invitae to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021 (PR Newswire)
11.06.21	Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer (PR Newswire)
05.04.21	Invitae Reports Investment Of $1.15 Bln In Convertible Senior Notes - Quick Facts (RTTNews)
05.04.21	Invitae To Acquire Genosity For $200 Mln In Cash, Stock - Quick Facts (RTTNews)
07.12.20	Stock Alert: Invitae Corporation Touches New High (RTTNews)
27.08.20	Pre-market Movers In Healthcare Sector: EYPT, CLVS, ABT, VBIV, LPCN... (RTTNews)
23.06.20	MYOV To Report SPIRIT 1 Data, EVLO Joins COVID-19 Drug Race, NVTA Loosens Purse Strings (RTTNews)
20.11.19	Did These Stocks Catch Your Eye? (ZYME, NVTA) (RTTNews)
06.03.19	BIOL On Watch, CELG Faces FDA In Sep., Scott Gottlieb Resigns (RTTNews)
21.02.19	8 Top Gainers In Healthcare Sector (LMAT, CLSD, LNTH...) (RTTNews)
20.02.19	FDA Nod For NVO's Hemophilia A Drug, ICPT's NASH Trial Hits Goal, NVTA Abuzz (RTTNews)
20.09.18	UBX To Report Phase I Data In Q1, NVTA On Watch, NTGN Faces Busy Year Ahead (RTTNews)
13.06.18	Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing (PR Newswire)
30.05.18	Invitae to Present at the William Blair 2018 Growth Stock Conference (PR Newswire)
24.05.18	Quick Base and Workato Expand Strategic Partnership to Bolster No-Code Workflows in the Enterprise (PR Newswire)
10.05.18	FDA Snubs LPCN Again, NVTA Boosts Revenue Outlook, New Lease Of Life For VTVT (RTTNews)
09.05.18	Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018 (PR Newswire)
07.05.18	Sarepta and Invitae Expand Partnership to Advance Clinical Research in Duchenne Muscular Dystrophy (PR Newswire)
03.05.18	Invitae to participate in two upcoming investor conferences, the Bank of America Merrill Lynch 2018 Heath Care Conference and the UBS Global Healthcare Conference (PR Newswire)
27.04.18	Invitae Announces New Program to Offer Genetic Testing to Aid Diagnosis of Spinal Muscular Atrophy (SMA) (PR Newswire)
25.04.18	Invitae to Announce First Quarter 2018 Financial Results on May 9, 2018 (PR Newswire)
10.04.18	Invitae research highlights utility of proactive genetic screening, importance of assessing secondary findings in genetic testing (PR Newswire)
22.03.18	Invitae expands network of patients in rare and ultra-rare diseases (PR Newswire)
16.03.18	Invitae partners with KEW, Inc. to develop somatic mutation detection capabilities to improve cancer care by providing comprehensive genomic information (PR Newswire)
27.02.18	Invitae expands existing credit facility to provide up to $40.0 million in available growth capital (PR Newswire)
26.02.18	Invitae to present at the Cowen and Company 38th Annual Health Care Conference (PR Newswire)
12.02.18	Invitae reports over 150% volume and over 170% revenue growth for 2017 (PR Newswire)
31.01.18	Invitae to participate in two upcoming investor conferences, including the 2018 BIO CEO & Investor Conference and Leerink Partners 7th Annual Global Healthcare Conference (PR Newswire)
29.01.18	Invitae to announce fourth quarter and year-end 2017 financial results on February 12, 2018 (PR Newswire)
08.01.18	Invitae more than doubles annual volume, exceeds full-year 2017 guidance, and projects momentum to continue in 2018 (PR Newswire)
05.12.17	Multigene Genetic Testing Improves Identification and Management of Hereditary Cancer Risk for Breast Cancer Patients and Their Families (PR Newswire)
15.11.17	Invitae Completes Acquisition of CombiMatrix, Becoming a Leader in Family and Reproductive Health Genetic Information Services (PR Newswire)
13.11.17	FDA Nod For BMY's Sprycel, ARNA To Report Data In Q1, MYL Delists From TASE (RTTNews)
06.11.17	Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017 (PR Newswire)
30.10.17	Invitae Presents Validation of a Novel NGS-based Preimplantation Genetic Screening Technology to Identify the Most Frequent Chromosomal Causes of Miscarriage (PR Newswire)
26.10.17	Safeguard Scientifics Announces Third Quarter 2017 Financial Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Invitae Corp

Aktien Top/Flop

Meistgelesene Nachrichten